Literature DB >> 26913812

Pharmacy-led medication reconciliation programmes at hospital transitions: a systematic review and meta-analysis.

Alemayehu B Mekonnen1,2, Andrew J McLachlan1,3, Jo-Anne E Brien1,4.   

Abstract

WHAT IS KNOWN AND
OBJECTIVE: Medication reconciliation is recognized as an important tool for the prevention of medication discrepancies and subsequent patient harm at care transitions. However, there is inconclusive evidence as to the impact of medication reconciliation at hospital transitions overall, as well as pharmacy-led medication reconciliation services. This review sought to evaluate the impact of pharmacy-led medication reconciliation interventions on medication discrepancies at hospital transitions and to categorize these interventions as single transition interventions or multiple transitions interventions.
METHODS: PubMed, MEDLINE, EMBASE, IPA, CINHAL and PsycINFO databases, inclusive from inception to December 2014, were searched. Included studies were published studies in English that compared the effectiveness of pharmacy-led medication reconciliation interventions to usual care and that aimed to assess medication discrepancies at hospital transitions. 'Usual care' was defined as any care where targeted medication reconciliation was not undertaken as an intervention, or if an intervention was conducted, it was not provided by a pharmacist/pharmacy technician. RESULTS AND DISCUSSION: Nineteen studies which involved a total of 15 525 adult patients were included. Eleven studies were randomized controlled trials. Overall, pharmacy-led medication reconciliation intervention usually revealed a trend towards reduction in medication discrepancies, compared with usual care. Seventeen studies involving 18 medication reconciliation interventions targeting the various transitions (admission, 9; discharge, 4; and multiple transitions, 5) were included in the meta-analysis. Compared with usual care, single medication reconciliation interventions at transitions in care (either admission or discharge) showed a significant reduction of 66% in patients with medication discrepancies (RR 0·34; 95% CI: 0·23-0·50) in favour of the intervention. There was no difference between groups for interventions targeting multiple transitions (RR 0·88; 95% CI: 0·77-1·02). Subgroup analyses confined to RCTs showed that there were no differences for target of transition (admission vs. discharge), type of intervention (multifaceted intervention vs. medication reconciliation) and setting (single centre vs. multicentre), nor pharmacists vs. pharmacy technicians (non-RCTs only). Importantly, medication discrepancies of higher clinical impact were more easily identified through pharmacy-led interventions than with usual care. WHAT IS NEW AND
CONCLUSION: Pharmacy-led medication reconciliation interventions were found to be an effective strategy to reduce medication discrepancies, and had a greater impact when conducted at either admission or discharge but were less effective during multiple transitions in care. Further studies that are designed to assess the impact of the involvement of pharmacy technicians in medication reconciliation are also needed.
© 2016 John Wiley & Sons Ltd.

Entities:  

Keywords:  care transition; hospital; medication discrepancies; medication errors; medication reconciliation; medication review; pharmacy

Mesh:

Year:  2016        PMID: 26913812     DOI: 10.1111/jcpt.12364

Source DB:  PubMed          Journal:  J Clin Pharm Ther        ISSN: 0269-4727            Impact factor:   2.512


  60 in total

1.  Comment to: What are the problems, information needs and objectives of community pharmacists? A mixed method approach.

Authors:  Ché M Harris; Catherine Kiruthi; Elsen Jacob
Journal:  Pharm Pract (Granada)       Date:  2017-12-17

2.  Pharmacy in the 21st century: Enhancing the impact of the profession of pharmacy on people's lives in the context of health care trends, evidence and policies.

Authors:  Lisa Dolovich; Zubin Austin; Nancy Waite; Feng Chang; Barbara Farrell; Kelly Grindrod; Sherilyn Houle; Lisa McCarthy; Lori MacCallum; Beth Sproule
Journal:  Can Pharm J (Ott)       Date:  2018-12-25

3.  Evaluation of the impact of pharmacist-led medication reconciliation intervention: a single centre pre-post study from Ethiopia.

Authors:  Alemayehu B Mekonnen; Andrew J McLachlan; Jo-Anne E Brien; Desalew Mekonnen; Zenahbezu Abay
Journal:  Int J Clin Pharm       Date:  2018-08-28

4.  Supporting Community Pharmacies with Implementation of a Web-Based Medication Management Application.

Authors:  Kea Turner; Chelsea Renfro; Stefanie Ferreri; Kim Roberts; Trista Pfeiffenberger; Christopher M Shea
Journal:  Appl Clin Inform       Date:  2018-05-30       Impact factor: 2.342

5.  Impact of medication reconciliation for improving transitions of care.

Authors:  Patrick Redmond; Tamasine C Grimes; Ronan McDonnell; Fiona Boland; Carmel Hughes; Tom Fahey
Journal:  Cochrane Database Syst Rev       Date:  2018-08-23

6.  Pharmacist-led pre-treatment assessment, management and outcomes in a Hepatitis C treatment patient cohort.

Authors:  Miriam Coghlan; Aisling O'Leary; Gail Melanophy; Colm Bergin; Suzanne Norris
Journal:  Int J Clin Pharm       Date:  2019-07-11

7.  Exploring discharge prescribing errors and their propagation post-discharge: an observational study.

Authors:  Ciara O' Riordan; Tim Delaney; Tamasine Grimes
Journal:  Int J Clin Pharm       Date:  2016-07-29

8.  Impact of Inpatient Automatic Therapeutic Substitutions on Postdischarge Medication Prescribing.

Authors:  Pooja J Shah; Jennifer L Cruz; Ashley L Pappas; Kayla M Waldron; Scott W Savage
Journal:  Hosp Pharm       Date:  2017-08-29

9.  Evaluation of Pharmacist Involvement in Outpatient Transitions of Care.

Authors:  Adam S Whalley; Marissa C Salvo; Susan F Levine; Kevin W Chamberlin; Danielle Beaudoin
Journal:  J Gen Intern Med       Date:  2018-08       Impact factor: 5.128

10.  Effect of medication reconciliation interventions on outcomes: A systematic overview of systematic reviews.

Authors:  Laura J Anderson; Jeff L Schnipper; Teryl K Nuckols; Rita Shane; Michael M Le; Karen Robbins; Joshua M Pevnick
Journal:  Am J Health Syst Pharm       Date:  2019-12-02       Impact factor: 2.637

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.